61 – 70 of 147
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Chromosome 9p21 genetic variation explains 13% of cardiovascular disease incidence but does not improve risk prediction.
(
- Contribution to journal › Article
- 2012
-
Mark
The Renalase Asp37Glu polymorphism is not associated with hypertension and cardiovascular events in an urban-based prospective cohort: the Malmo Diet and cancer study
(
- Contribution to journal › Article
-
Mark
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
(
- Contribution to journal › Article
-
Mark
From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population.
(
- Contribution to journal › Article
-
Mark
Prediction of Blood Pressure Changes Over Time and Incidence of Hypertension by a Genetic Risk Score in Swedes.
2012) In Hypertension(
- Contribution to journal › Article
-
Mark
Genetic Polymorphisms for Estimating Risk of Atrial Fibrillation in the General Population: A Prospective Study
(
- Contribution to journal › Letter
-
Mark
Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.
(
- Contribution to journal › Article
-
Mark
Orthostatic hypotension and novel blood pressure-associated gene variants: Genetics of Postural Hemodynamics (GPH) Consortium.
(
- Contribution to journal › Article
-
Mark
A myocardial infarction genetic risk score is associated with markers of carotid atherosclerosis.
(
- Contribution to journal › Article
-
Mark
Pharmacogenetic implications for eight common blood pressure-associated single-nucleotide polymorphisms.
(
- Contribution to journal › Article